Lipedema diagnosis is heavily reliant on patient history. Various objective assessments have been suggested; however, a standardized measurement process is lacking. A systematic review was undertaken to identify which imaging and measurement tools are used in lipedema quantification and to review their protocols. Six databases were searched with two reviewers screening citations for inclusion. Full peer-reviewed publications that included defined lipedema diagnosis criteria, no male cases within comparative cohorts, and used an imaging or measurement tool to quantify lipedema were included. Twenty studies met the inclusion criteria using 13 different tools to quantify individual physical lipedema characteristics to either enable differential diagnosis, and/or quantify treatment effect: tape measure, perometry, durometry, tonometry, bioimpedance spectroscopy, tissue di-electric constant, ultrasound, Dual-Energy X-ray Absorptiometry, magnetic resonance imaging (MRI), noncontrast MRI lymphangiography, Indocyanine green lymphography, lymphoscintigraphy, and dynamic lymphangiography. Eight imaging and five measurement tools assessed lymphatic transport disturbances (n = 8), limb size/volume (n = 4), adipose tissue thickness/mass/volume (n = 3), and tissue fluid presence (n = 2). Multiple tools were only used in studies completed in 2020 or later. A lack of consistency exists in tool protocols, measurement locations, and outcome analysis. Limited reporting of clinimetrics with data derived from small cohorts and heterogenous populations impacted the ability to recommend tools for clinical practice and research. Various tools were used for objective lipedema assessment; however, consistency in approach was lacking. Further investigations are required to establish the validity and reliability of measurement and imaging tools, protocols, measurement points, and outcome reporting/interpretation to quantify the physical attributes of lipedema.
Get full access to this article
View all access options for this article.
References
1.
SzelE, KemenyL, GromaG, et al.Pathophysiological dilemmas of lipedema. Med Hypotheses, 2014; 83(5):599–606.
2.
ShavitE, WollinaU, AlaviA. Lipoedema is not lymphoedema: A review of current literature. Int Wound J, 2018; 15(6):921–928.
3.
PaolacciS, PreconeV, AcquavivaF, et al.;GeneOb Project. Genetics of lipedema: New perspectives on genetic research and molecular diagnoses. Eur Rev Med Pharmacol Sci, 2019; 23(13):5581–5594.
4.
Di RenzoL, GualtieriP, AlwardatN, et al.The role of IL-6 gene polymorphisms in the risk of lipedema. Eur Rev Med Pharmacol Sci, 2020; 24(6):3236–3244.
5.
AndersenMT, BurianEA, NissenCV, et al.Lipoedema. Ugeskrift for Laeger, 2022; 184(51).
6.
IshaqM, BandaraN, MorganS, et al.Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema. Int J Obes (Lond), 2022; 46(3):502–514.
7.
GrigoriadisD, SackeyE, RichesK, et al.;Genomics England Research Consortium. Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort. PLoS One, 2022; 17(10):e0274867.
8.
KlimentidisYC, ChenZ, Gonzalez-GarayML, et al.Genome-wide association study of a lipedema phenotype among women in the UK Biobank identifies multiple genetic risk factors. Eur J Hum Genet, 2023; 31(3):338–344.
9.
AksoyH, KaradagAS, WollinaU. Cause and management of lipedema-associated pain. Dermatol Ther, 2021; 34(1):e14364.
10.
AngstF, BenzT, LehmannS, et al.Common and contrasting characteristics of the chronic soft-tissue pain conditions fibromyalgia and lipedema. J Pain Res, 2021; 14:2931–2941.
11.
GensiorMHL, CornelyM. Pain in lipoedema, fat in lipoedema and its consequences: Results of a patient survey based on a pain questionnaire. [German]. Phlebologie, 2021; 50(5):330–335.
12.
BrennerE. How does the pain get into lipedema? [German]. Vasomed, 2017; 29(4):174–175.
13.
ChakrabortyA, CrescenziR, UsmanTA, et al.Indications of peripheral pain, dermal hypersensitivity, and neurogenic inflammation in patients with lipedema. Int J Mol Sci, 2022; 23(18):7–23.
14.
ErbacherG, BertschT. Lipoedema and pain: What is the role of the psyche? results of a pilot study with 150 patients with lipoedema. Phlebologie, 2020; 49(05):305–316.
15.
SchmellerW, Meier-VollrathI. Describing pain in lipedema - An approach. Lymphologie in Forschung Und Praxis, 2008; 12(1):7–11.
16.
BertschT, ErbacherG, ElwellR. Lipoedema: A paradigm shift and consensus. J Wound Care, 2020; 29(Sup11b):1–51.
17.
Forner-CorderoI, Forner-CorderoA, SzolnokyG. Update in the management of lipedema. Int Angiol, 2021; 40(4):345–357.
18.
HalkAB, DamstraRJ. First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Phlebology, 2017; 32(3):152–159.
19.
HerbstKL, KahnLA, IkerE, et al.Standard of care for lipedema in the United States. Phlebology, 2021; 36(10):779–796.
UK W. Best Practice Guidelines: The Management of Lipoedema. Wounds UK: London; 2017.
22.
AtanT, Bahar-OzdemirY. The effects of complete decongestive therapy or intermittent pneumatic compression therapy or exercise only in the treatment of severe lipedema: A randomized controlled trial. Lymphat Res Biol, 2021; 19(1):86–95.
23.
BirkballeS, JensenMR, NoerregaardS, et al.Can tissue dielectric constant measurement aid in differentiating lymphoedema from lipoedema in women with swollen legs? Br J Dermatol, 2014; 170(1):96–102.
24.
BusoG, FavreL, VionnetN, et al.Body composition assessment by dual-energy X-Ray absorptiometry: A useful tool for the diagnosis of lipedema. Obes Facts, 2022; 15(6):762–773.
25.
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 2021; 372(71):1–9.
26.
ChachajA, DudkaI, JeziorekM, et al.Lymphoscintigraphic alterations in lower limbs in women with lipedema in comparison to women with overweight/obesity. Front Physiol, 2023; 14:1099555.
27.
CzerwińskaM, TeodorczykJ, SpychałaD, et al.The usefulness of the application of compression therapy among lipedema patients-pilot study. Int J Environ Res Public Health, 2023; 20(2).
28.
MackieH, ThompsonBM, SuamiH, et al.Differentiation of lipoedema from bilateral lower limb lymphoedema by imaging assessment of indocyanine green lymphography. Clin Obes, 2023; 13(3):e12588.
29.
WrightT, ScarfinoCD, O’MalleyEM. Effect of pneumatic compression device and stocking use on symptoms and quality of life in women with lipedema: A proof-in-principle randomized trial. Phlebology, 2023; 38(1):51–61.
30.
FinkJM, SchreinerL, MarjanovicG, et al.Leg volume in patients with lipoedema following bariatric surgery. Visc Med, 2021; 37(3):206–211.
31.
SchneiderR. Low-Frequency Vibrotherapy Considerably Improves the Effectiveness of Manual Lymphatic Drainage (MLD) in Patients with Lipedema: A two-armed, Randomized, Controlled Pragmatic Trial. Taylor & Francis Ltd: Philadelphia, Pennsylvania; 2020. Report No.: 0959-3985.
32.
CrescenziR, DonahuePMC, PetersenKJ, et al.Upper and Lower Extremity Measurement of Tissue Sodium and Fat Content in Patients with Lipedema. Obesity (Silver Spring), 2020; 28(5):907–915.
33.
CrescenziR, DonahuePMC, WeakleyS, et al.Lipedema and dercum’s disease: A new application of bioimpedance. Lymphat Res Biol, 2019; 17(6):671–679.
34.
ZaleskaMT, OlszewskiWL, KrzesniakNE. Lower limb Lipedema-Superficial lymph flow, skin water concentration, skin and subcutaneous tissue elasticity. Lymphat Res Biol, 2023; 21(1):60–69.
35.
AmatoACM, SaucedoDZ, SantosKD, et al.Ultrasound criteria for lipedema diagnosis. Phlebology, 2021; 36(8):651–658.
36.
CrescenziR, DonahuePMC, GarzaM, et al.Subcutaneous adipose tissue edema in lipedema revealed by Noninvasive 3T MR Lymphangiography. J Magn Reson Imaging, 2023; 57(2):598–608.
37.
TaylorSL, DonahuePMC, PridmoreMD, et al.Semiautomated segmentation of lower extremity MRI reveals distinctive subcutaneous adipose tissue in lipedema: A pilot study. J Med Imaging (Bellingham), 2023; 10(3):036001.
38.
CellinaM, GibelliD, SoresinaM, et al.Non-contrast MR Lymphography of lipedema of the lower extremities. Magn Reson Imaging, 2020; 71:115–124.
39.
BusoG, FavreL, MaufusM, et al.Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema. Microvasc Res, 2022; 140(no pagination):104298.
40.
GouldDJ, El-SabawiB, GoelP, et al.Uncovering lymphatic transport abnormalities in patients with primary lipedema. J Reconstr Microsurg, 2020; 36(2):136–141.
41.
Forner-CorderoI, Olivan-SasotP, Ruiz-LlorcaC, et al.Lymphoscintigraphic findings in patients with lipedema. Rev Esp Med Nucl Imagen Mol (Engl Ed), 2018; 37(6):341–348.
42.
BilanciniS, LucchiM, TucciS, et al.Functional lymphatic alterations in patients suffering from lipedema. Angiology, 1995; 46(4):333–339.
43.
Wounds UK. Best Practice Guidelines: The Management of Lipoedema. Wounds UK: London; 2017.
44.
CrescenziR, DonahuePMC, GarzaM, et al.Subcutaneous adipose tissue edema in lipedema revealed by Noninvasive 3T MR lymphangiography. Journal of Magnetic Resonance Imaging, 2022[Mismatch
45.
LohrmannC, FoeldiE, LangerM. MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema. Microvasc Res, 2009; 77(3):335–339.
46.
ErbacherG, MendozaE, BertschT. Swelling tendency of the thighs and hematoma tendency in female patients with lipedema - Subjective perception versus objective examination. Vasomed, 2023; 35(1):8–17.
47.
DeVetH, TerweeCB, MokkinkLB, et al.Measurement in Medicine: A Practical Guide. 1st ed. Cambridge University Press; 2011.
48.
StantonA, BadgerC, SitziaJ. Non-invasive assessment of the lymphedematous limb. Lymphology, 2000; 33(3):122–135.
49.
StantonA, NorthfieldJ, HolroydB, et al.Validation of an optoelectronic limb volumeter (Perometer®). Lymphology, 1997; 30(2):77–97.
50.
TierneyS, AslamM, RennieK, et al.Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg, 1996; 12(4):412–417.
51.
Leduc 0KP, RasquinC, DemaretP. Reliability of a volume measuring device (Volumeter®) for human limbs. European Journal of Lymphology, 1992; 3:53–56.
52.
LabsK-H, TschoeplM, GambaG, et al.The reliability of leg circumference assessment: A comparison of spring tape measurements and optoelectronic volumetry. Vasc Med, 2000; 5(2):69–74.
53.
MazessRB, BardenHS, BisekJP, et al.Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr, 1990; 51(6):1106–1112.
54.
SteeleML, JandaM, VagenasD, et al.A bioimpedance spectroscopy-based method for diagnosis of lower-limb lymphedema. Lymphat Res Biol, 2020; 18(2):101–109.
55.
JönssonC, JohanssonK, BjurbergM, et al.Impedance of extracellular fluid, volume, and local tissue water can be reliably measured in people with lower limb lymphedema. Phys Ther, 2022; 102(5):pzac025.
56.
RastelD, CrébassaV, RouvièreD, et al.Physician interpretation of ultrasound in the evaluation of ankle edema. Phlebology, 2020; 35(8):623–630.
57.
KilbreathSL, FearnNR, DylkeES. Ultrasound: Assessment of breast dermal thickness: Reliability, responsiveness to change, and relationship to patient‐reported outcomes. Skin Res Technol, 2022; 28(1):111–118.
58.
PolatAV, MesutO, PolatAK, et al.Efficacy of ultrasound and shear wave elastography for the diagnosis of breast cancer–related lymphedema. J Ultrasound Med, 2020; 39(4):795–803.
59.
PhillipsJ, ReynoldsKJ, GordonSJ. Dermal thickness and echogenicity using DermaScan C high frequency ultrasound: Methodology and reliability testing in people with and without primary lymphoedema. Skin Res Technol, 2020; 26(6):813–823.
60.
DouglassJ, GravesP, GordonS. Intrarater reliability of tonometry and bioimpedance spectroscopy to measure tissue compressibility and extracellular fluid in the legs of healthy young people in Australia and Myanmar. Lymphat Res Biol, 2017; 15(1):57–63.
61.
SunD, YuZ, ChenJ, et al.The value of using a SkinFibroMeter for diagnosis and assessment of secondary lymphedema and associated fibrosis of Lower Limb Skin. Lymphat Res Biol, 2017; 15(1):70–76.
62.
MiharaM, HaraH, ArakiJ, et al.Indocyanine Green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS One, 2012; 7(6):e38182.
63.
BorriM, GordonKD, HughesJC, et al.Magnetic resonance imaging–based assessment of breast cancer–related lymphoedema tissue composition. Invest Radiol, 2017; 52(9):554–561.
64.
SalehiBP, SibleyRC, FriedmanR, et al.MRI of Lymphedema. J Magn Reson Imaging, 2023; 57(4):977–991.
65.
CrescenziR, DonahuePM, HartleyKG, et al.Lymphedema evaluation using noninvasive 3T MR lymphangiography. J Magn Reson Imaging, 2017; 46(5):1349–1360.
66.
Van la ParraRFD, DeconinckC, KrugB. Diagnostic imaging in lipedema: A systematic review. Obes Rev, 2024; 25(1):e13648.
67.
LuQ, XuJ, LiuN. Chronic lower extremity lymphedema: A comparative study of high-resolution interstitial MR lymphangiography and heavily T2-weighted MRI. Eur J Radiol, 2010; 73(2):365–373.
68.
ArrivéL, DerhyS, DahanB, et al.Primary lower limb lymphoedema: Classification with non-contrast MR lymphography. Eur Radiol, 2018; 28(1):291–300.
69.
WhiteR, Weir-McCallJ, BudakM, et al.Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol, 2014; 69(11):e435–e44.
70.
BourgeoisP, RocksonSG. Combined role of lymphoscintigraphy, x-ray computed tomography, magnetic resonance imaging, and positron emission tomography in the management of lymphedematous disease. Lymphedema: a Concise Compendium of Theory and Practice, 2018:367–385.
71.
MarkarianB, ToroC, MoreiraKP, et al.Assessment Modalities for Lower Extremity Edema, Lymphedema, and Lipedema: A Scoping Review. Cureus, 2024; 16(3):e55906.
72.
WardL, WinallA, IsenringE, et al.Assessment of bilateral limb lymphedema by bioelectrical impedance spectroscopy. International Journal of Gynecologic Cancer, 2011; 21(2).
73.
JensenMR, BirkballeS, NorregaardS, et al.Validity and interobserver agreement of lower extremity local tissue water measurements in healthy women using tissue dielectric constant. Clin Physiol Funct Imaging, 2012; 32(4):317–322.
74.
WarnerRR, MyersMC, TaylorDA. Electron probe analysis of human skin: Determination of the water concentration profile. J Invest Dermatol, 1988; 90(2):218–224.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
